ArticleClinical and experimental medicine2026
Bortezomib synergizes with homoharringtonine in FLT3-ITD-relapsed/refractory acute myeloid leukemia by inducing FLT3-ITD protein degradation.
Ming Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.